CONDOR project wants to revolutionize by 2027 the therapeutic management of soft tissue sarcomas patients with 1 coordinator + 7 strategic partners...
CONDOR project wants to revolutionize by 2027 the therapeutic management of soft tissue sarcomas patients with 1 coordinator + 7 strategic partners...
CONDOR project wants to revolutionize by 2027 the therapeutic management of soft tissue sarcomas patients with 1 coordinator + 7 strategic partners...

WELCOME
ON THE CONDOR PROGRAM WEBSITE

CONDOR project wants to revolutionize by 2027 the therapeutic management of soft tissue sarcomas (STS) patients.

STS are rare tumours of mesenchymal origin, comprising ~1% of all adult cancers and 15% in Patients, +4,500 adults and children each year in France, and 500,000 worldwide. Up to 40% of STS patients will develop metastatic disease.

0
PARTNERS
0
WORK PACKAGES
>0
BIOLOGICAL SAMPLES

THE PROJECT

1 coordinator + 7 strategic partners = 1 objective:

Establishing immunotherapy as a standard for sarcoma

CONDOR project wants to revolutionize by 2027 the therapeutic management of soft tissue sarcomas patients with 1 coordinator + 7 strategic partners...
CONDOR project wants to revolutionize by 2027 the therapeutic management of soft tissue sarcomas patients with 1 coordinator + 7 strategic partners...
CONDOR project wants to revolutionize by 2027 the therapeutic management of soft tissue sarcomas patients with 1 coordinator + 7 strategic partners...
CONDOR project wants to revolutionize by 2027 the therapeutic management of soft tissue sarcomas patients with 1 coordinator + 7 strategic partners...
CONDOR project wants to revolutionize by 2027 the therapeutic management of soft tissue sarcomas patients with 1 coordinator + 7 strategic partners...
CONDOR project wants to revolutionize by 2027 the therapeutic management of soft tissue sarcomas patients with 1 coordinator + 7 strategic partners...
CONDOR project wants to revolutionize by 2027 the therapeutic management of soft tissue sarcomas patients with 1 coordinator + 7 strategic partners...
CONDOR project wants to revolutionize by 2027 the therapeutic management of soft tissue sarcomas patients with 1 coordinator + 7 strategic partners...
LEARN MORE

This project has benefited from a government grant managed by the Agence Nationale de la Recherche
under the 3rd AIP, integrated into France 2030
with the reference
ANR-21-RHUS-0010.

CONDOR project wants to revolutionize by 2027 the therapeutic management of soft tissue sarcomas patients with 1 coordinator + 7 strategic partners...
CONDOR project wants to revolutionize by 2027 the therapeutic management of soft tissue sarcomas patients with 1 coordinator + 7 strategic partners...

CONSORTIUM

LEARN MORE
CONDOR project wants to revolutionize by 2027 the therapeutic management of soft tissue sarcomas patients with 1 coordinator + 7 strategic partners...

EVENTS & PRESENTATION

LEARN MORE

SUBSCRIBE
TO OUR
NEWSLETTER

MEMBER ACCESS
CONDOR project wants to revolutionize by 2027 the therapeutic management of soft tissue sarcomas patients with 1 coordinator + 7 strategic partners...
MAKE A DONATION